XML 29 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Fair Value of Financial Assets and Liabilities (Tables)
3 Months Ended
Mar. 31, 2018
Schedule of fair value assets and liabilities

The following table presents the Company’s assets and liabilities that are measured at fair value at March 31, 2018 and December 31, 2017 ($ in thousands):

 

    Fair value measured at March 31, 2018  
    Total carrying value at March 31,     Quoted prices in active markets     Significant other observable inputs     Significant unobservable inputs  
    2018     (Level 1)     (Level 2)     (Level 3)  
Assets                        
Marketable securities - mutual and exchange traded funds   $ 5,574     $     $ 5,574     $  
Investments at fair value   $ 1,045     $     $     $ 1,045  
                                 
Liabilities                                
Fair value of warrant liabilities   $ 634     $     $     $ 634  

 

    Fair value measured at December 31, 2017  
    Total carrying value at December 31,     Quoted prices in active markets     Significant other observable inputs     Significant unobservable inputs  
    2016     (Level 1)     (Level 2)     (Level 3)  
Assets                        
Marketable securities - mutual and exchange traded funds   $ 3,998     $     $ 3,998     $  
Investments at fair value   $ 1,020     $     $     $ 1,020  
                                 
Liabilities                                
Fair value of warrant liabilities   $ 822     $     $     $ 822  
Schedule of fair value assumptions

A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s warrant liabilities that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of March 31, 2018 and December 31, 2017 is as follows:

 

Warrants        
Date of valuation   March 31, 2018   December 31, 2017
Risk-free interest rate   2.39%   1.98%
Expected volatility   100.00% - 135.30%   100.00% - 132.21%
Expected life (in years)   2.69-2.81   2.94 - 3.06
Expected dividend yield    

Schedule of fair value of the company's level 3 financial liabilities

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial liabilities for the three months ended March 31, 2018 and 2017 that are measured at fair value on a recurring basis ($ in thousands):

 

    Fair Value of Level 3 financial liabilities  
    March 31,
2018
    March 31,
2017
 
Beginning balance   $ 822     $ 702  
Fair value adjustment of warrant liabilities     (188 )     122  
Ending balance   $ 634     $ 824  
Schedule of fair value of the Company's Level 3 financial assets

The following table sets forth a summary of the changes in the fair value of the Company’s Level 3 financial assets for the three months ended March 31, 2018 and 2017 that are measured at fair value on a recurring basis:

 

    Fair Value of Level 3 financial liabilities  
    March 31,
2018
    March 31,
2017
 
Beginning balance   $ 1,020     $  
Purchase of investment in TheBit Daily LLC at fair value     25        
Ending balance   $ 1,045     $  
Hoth Therapeutics, Inc [Member]  
Schedule of fair value assumptions

A summary of quantitative information with respect to the valuation methodology and significant unobservable inputs used for the Company’s valuation in Hoth that are categorized within Level 3 of the fair value hierarchy at the date of issuance and as of March 31, 2018 and December 31, 2017 is as follows:

 

Date of valuation   March 31, 2018     December 31, 2017  
Risk-free interest rate     1.39 %     1.39 %
Expected volatility     75.00 %     75.00 %
Expected life (in years)     0.75       1.00